# Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers

> **NCT03203564** · PHASE1 · COMPLETED · sponsor: **Isofol Medical AB** · enrollment: 33 (actual)

## Conditions studied

- Phase I Study in Healthy Volunteers to Evaluate ECG Effect

## Interventions

- **DRUG:** Modufolin (arfolitixorin)

## Key facts

- **NCT ID:** NCT03203564
- **Lead sponsor:** Isofol Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2017-08-25
- **Final completion:** 2017-08-25
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03203564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03203564, "Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03203564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*